Avalo Therapeutics, Inc. - Class A Common Stock (AVTX)

Historical Holders from Q4 2023 to Q3 2025

Symbol
AVTX on Nasdaq
Type / Class
Equity / Class A Common Stock
Shares outstanding
13,155,511
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
15,317,685
Holdings value
$194,685,792
% of all portfolios
0.002%
Number of holders
65
Number of buys
47
Number of sells
-10
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Avalo Therapeutics, Inc. - Class A Common Stock (AVTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOTECHNOLOGY VALUE FUND L P 9.99% 0% $18,533,099 +$5,333,230 1,458,151 +40.4% BVF PARTNERS L P/IL 30 Sep 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% 0% $17,618,183 +$3,708,270 1,386,167 +26.7% RA Capital Management, L.P. 30 Sep 2025
Nantahala Capital Management, LLC 9.39% +12% $15,696,850 +$4,257,850 1,235,000 +37.2% Nantahala Capital Management, LLC 30 Sep 2025
Point72 Asset Management, L.P. 8% +52% $13,396,124 +$5,914,611 1,053,983 +79.1% Point72 Asset Management, L.P. 30 Sep 2025
Affinity Asset Advisors, LLC 7.65% +47% $12,789,018 +$5,788,795 1,006,217 +82.7% Affinity Healthcare Fund, LP 30 Sep 2025
ORBIMED ADVISORS LLC 8.9% $4,622,260 967,000 OrbiMed Advisors LLC 30 Jun 2025
Caligan Partners LP 6.3% $10,591,662 833,333 Caligan Partners LP 30 Sep 2025
BALYASNY ASSET MANAGEMENT L.P. 6.22% $10,389,612 817,436 Balyasny Asset Management L.P. 30 Sep 2025
SILVERARC CAPITAL MANAGEMENT, LLC 5.48% $9,162,919 720,922 SilverArc Capital Management, LLC 30 Sep 2025
Ikarian Capital, LLC 3.8% -61.9% $9,049,101 -$6,100,673 711,967 -40.3% Ikarian Capital, LLC 30 Sep 2025
VANGUARD GROUP INC 5.26% $8,803,416 692,637 The Vanguard Group 30 Sep 2025
Crutcher Patrick J 4.2% $3,593,514 549,467 Patrick J. Crutcher 06 Aug 2025

Institutional Holders of Avalo Therapeutics, Inc. - Class A Common Stock (AVTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 15,317,685 $194,685,792 +$95,069,684 $12.71 65
2025 Q2 7,843,040 $39,137,186 -$2,087,558 $4.99 35
2025 Q1 8,255,057 $66,123,710 +$5,779,142 $8.01 33
2024 Q4 7,530,521 $55,951,612 +$4,829,815 $7.43 33
2024 Q3 6,656,933 $63,199,568 +$55,874,127 $9.5 28
2024 Q2 771,102 $9,615,066 +$8,430,049 $12.47 21
2024 Q1 87,507 $1,897,924 +$1,405,693 $21.75 18
2023 Q4 22,966 $209,366 +$209,366 $9 12